Infection Rates And Phylogenetic Analysis Of Hepatitis G Virus (hgv)/gb Virus C (gbv-c) Among Qatari Blood Donors

Background: A new immerging nonpathogenic single stranded human RNA virus known as GBV-C/HGV was discovered in 1995. Both GBV-C virus and HCV have similar genome, but they replicate in different cell types. The incidence of GBV-C infection has been studied worldwide, however, to our knowledge; no previous studies were conducted in Qatar, thus the objectives of this study are: (i) to determine the rate of GBV-C infection in Qatar among healthy blood donors and liver-diseased patient and (ii) to determine the most predominant GBV-C genotype in Qatar. Methods: 755 blood plasma samples from blood bank (593) and virology section (162) at HMC were collected. RNA was extracted, reversed transcribed, and then subjected for GBV-C detection by nested PCR using primers targeting a 205 bp of the 5' hypervariable untranslated region (5'-UTR) of the GBV-C/HGV. For genotyping, the 5'-UTR PCR product were T/A cloned into pDrive plasmid. The plasmids were transformed into DH5α™, and then plasmids were purified and digested by EcoRI to detect the positive clones. Plasmid were then purified and sequenced. Phylogenetic analysis was conducted by analyzing the 5'-UTR sequence from randomly picked positive clones. The resulted sequences were assembled and analyzed using CLC and MEGA5 software. Results: we found that HGV infection rate among healthy blood donors was 13.5 %, while in liver-diseased patient was 8.6 %. Moreover, there was no significant difference in the GBV-C infection rate among Qatari (13.3%) and Non-Qatari (14.4%) healthy donors. Sequence analysis of 25 5'-UTR PCR amplicons yielded the European genotype (genotype 2) as the most predominant in Qatar. Conclusion: Our results indicate that there is no correlation between GVC- infection rate and other liver-infecting viruses such as HB&CV. Not surprising, genotype 2 was also reported to be dominant in countries surrounding Qatar such as UAE and Kuwait. Finally, we think our results should benefit epidemiologists in the region and may have an impact on the blood screening policy in blood banks.qscienc

Seroprevalence of hepatitis E virus (HEV) among male craft and manual workers in Qatar (2020–2021)

BackgroundThe rapid growth of Qatar in the last two decades has attracted a large influx of immigrant craft and manual workers (CMWs) seeking employment in jobs associated with food handling, domestic service, and construction. Nearly 60 % of Qatar's population are expatriates CMWs, including many from hyperendemic countries for HEV. Thus, estimating the seroprevalence of HEV in Qatar and understanding its epidemiology is essential for public health efforts to control HEV transmission in Qatar. MethodsBlood samples from 2670 CMWs were collected between 2020 and 2021. All samples were tested for HEV-IgG antibodies. Positive HEV-IgG samples were tested for HEV-IgM antibodies, and those positives were also tested for viral antigens using an HEV-Ag ELISA kit and HEV-RNA by RT-PCR to confirm current HEV infections. ResultsThe seroprevalence of HEV-IgG was 27.3 % (729/2670; 95 % CI: 25.6–29.0). Of those HEV-IgG positive, 8.23 % (60/729; 95 % CI: 6.30–10.5) were HEV-IgM positive. Of the IgM-positive samples, 2 were HEV-RNA positive (3.39 %; 95 % CI: 0.40–11.7), and 1 was HEV-Ag positive (1.69 %; 95 % CI: 0.04–9.09). In addition, HEV-IgG seroprevalence was associated with age and nationality, with the highest seroprevalence in participants from Egypt (IgG 60.0 %; IgM 5.56 %), Pakistan (IgG 59.0 %; IgM 2.24 %), Nepal (IgG 29.3 %; IgM 2.70 %), Bangladesh (IgG 27.8 %; IgM 2.45 %), and India (IgG 23.9 %; IgM 2.43 %). ConclusionIn this study, we showed that the seroprevalence of HEV among CMWs was slightly higher than what was previously reported among the urban population in Qatar (2013–2016).This report was made possible by GSRA8-L-1-0501-21022 and NPRP13S-0128–200,185 from the Qatar National Research Fund (a member of Qatar Foundation). The funders had no role in study design, data collection, analysis, the decision to publish, or the preparation of the manuscript. The statements made herein are solely the responsibility of the authors. This study was approved by IRB at Qatar University (QU-IRB 1558-EA/21)

Detection and phylogenetic analysis of human pegivirus (GBV-C) among blood donors and patients infected with hepatitis B virus (HBV) in Qatar.

Human Pegivirus (HPgV), formerly GB virus-C/Hepatitis G virus (GBV-C/HGV), collectively known as GBV-C, is widely spread and has been reported to be associated with non-A-E hepatitis. To our knowledge, no previous study was conducted about HPgV in Qatar. Thus, the objectives of this study were as follows: (i) to determine the rates of HPgV infection in Qatar among healthy blood donors and HBV-infected patients, and (ii) to determine the most predominant HPgV genotype in Qatar. A total of 714 blood plasma samples from healthy donors (612) and HBV-infected patients (102) were collected. RNA was extracted, reversed transcribed, and then subjected for HPgV detection by two round-nested PCR using primers amplifying a 208 bp of 5'-UTR of the HPgV. For genotyping, the 5'-UTR PCR products (from 25 randomly picked samples) were cloned and sequenced. The overall infection rate of HPgV in Qatar was 13.3%. There was no significant difference (P = 0.41) in the infection rates between healthy donor (13.7%) and in HBV-infected patients (10.7%). Moreover, we did not find any significant association between HPgV infection rates and nationality, sex, or age (P > 0.05). Sequence analysis of 40 5'-UTR PCR amplicons yielded the European genotype 2 as most predominant in Qatar, although other genotypes (5 and 7) were also present. Our results indicate that there is no strong correlation between HPgV infection rate, condition, nationality, age, and sex, and genotype 2 is most predominant in Qatar.Qatar University. Grant Number: QUST-CAS-FALL-12/13-1 Hamad Medical Center Medical Research Committee. Grant Number: Protocol #13204/1

The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E

Abstract Background The rapid growth of Qatar in the last two decades has attracted a large influx of immigrant workers who mostly come from HEV-hyperendemic countries. Thus, we aim to investigate the prevalence of HEV among acute non-A-C hepatitis patients in Qatar; and to evaluate the performance of four dominant commercial serological assays for HEV diagnosis. Methods 259 patients with non-A-C hepatitis were tested using the Wantai HEV-IgM, HEV-IgG, HEV-Ag ELISA kits, and the MP Biomedical HEV-Total Ab ELISA kit. ALT levels were tested and HEV RNA (viral loads) was performed using Taqman AmpliCube HEV RT-PCR kit (Mikrogen, Neuried, Germany). The performance of each kit was assessed according to the RT-PCR results. Results HEV-RNA was detected in 23.1% of the samples. Most of these HEV-RNA-positive cases belonged to non-Qatari residents from the Indian subcontinent; India, Pakistan, etc. HEV-Ag, HEV-IgM, HEV-IgG, HEV-Total Ab were detected in 5.56%, 8.65%, 32.1%, and 34.2% of all tested samples, respectively. Elevated ALT levels were highly correlated with the HEV-Ag, HEV-IgM, HEV-RNA but not with the HEV-IgG and HEV-Total Ab. Although HEV-Ag was very specific (100%), yet its sensitivity was poor (36.7%). HEV-IgM demonstrated the best second marker for diagnosis of acute HEV after RT-PCR as jugged by the overall performance parameters: specificity (96.2%), sensitivity (71.4%), PPV (83.3%), NPP (92.7%), agreement with RT-PCR (91.0%), and Kappa-value (0.71). Conclusion Our study demonstrated a high prevalence of HEV virus in Qatar, mostly among immigrants from the Indian subcontinent. The HEV-IgM represents the best marker for detecting the acute HEV infection, where RT-PCR cannot be performed